Consonance Capital Management LP Compugen LTD Transaction History

Consonance Capital Management LP

  • $7.28 Million
  • Q3 2022

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2020

Feb 16, 2021
SELL
$12.07 - $17.95 $31.8 Million - $47.3 Million
-2,637,421 Closed
0 $0
Q3 2020

Nov 16, 2020
SELL
$14.16 - $19.45 $20.4 Million - $28 Million
-1,440,000 Reduced 35.32%
2,637,421 $42.9 Million
Q2 2020

Aug 14, 2020
BUY
$6.97 - $17.12 $28.4 Million - $69.8 Million
4,077,421 New
4,077,421 $61.2 Million

Others Institutions Holding CGEN

# of Institutions
73
Shares Held
13.1M
Call Options Held
79.2K
Put Options Held
12.7K
View Full List

About COMPUGEN LTD

CGEN Quotes by TradingView
  • Ticker CGEN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 86,624,600
  • Market Cap $131M
  • Description
  • Compugen Ltd., a clinical-stage therapeutic discovery and development company, researches, develops, and commercializes therapeutic and product candidates in Israel, the United States, and Europe. The company's immuno-oncology pipeline consists of COM701, an anti-PVRIG antibody that is in Phase I clinical study used for the treatment of solid tu...
More about CGEN
Track This Portfolio

Track Consonance Capital Management LP Portfolio

Follow Consonance Capital Management LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Consonance Capital Management LP, based on Form 13F filings with the SEC.

News

Stay updated on Consonance Capital Management LP with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email